Emerging Strategies for the Management of Atherogenic Dyslipidaemia

Código QR

Emerging Strategies for the Management of Atherogenic Dyslipidaemia

Guardado en:

Detalles Bibliográficos
Autores principales:	Anandita Agarwala, Michael D Shapiro
Formato:	article
Lenguaje:	EN
Publicado:	Radcliffe Medical Media 2020
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/7483fcaa6dc14e008533133bb1d2a40e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

New Perspectives on Atherogenic Dyslipidaemia and Cardiovascular Disease
por: Alberto J Lorenzatti, et al.
Publicado: (2020)

Management of Dyslipidaemia in Real-world Clinical Practice: Rationale and Design of the VIPFARMA ISCP Project
por: Ricardo Lopez Santi, et al.
Publicado: (2021)

Secondary Prevention of Cardiovascular Disease in Women: Closing the Gap
por: Aarti Thakkar, et al.
Publicado: (2021)

Current Evidence and Future Directions of PCSK9 Inhibition
por: Jiaqian Xu, et al.
Publicado: (2021)

Assessing Atherosclerotic Cardiovascular Disease Risk with Advanced Lipid Testing: State of the Science
por: Charles Amir German, et al.
Publicado: (2020)

Direct Oral Anticoagulants in Asian Patients with Atrial Fibrillation: Consensus Recommendations by the Asian Pacific Society of Cardiology on Strategies for Thrombotic and Bleeding Risk Management
por: Daniel TT Chong, et al.
Publicado: (2021)

Inflammation and Cardiovascular Disease: The Future
por: Natalie Arnold, et al.
Publicado: (2021)

Emergency Department Visits, Care, and Outcome After Stroke and Myocardial Infarction During the COVID-19 Pandemic Phases
por: Amy Y.X. Yu, MD, MSc, et al.
Publicado: (2021)

Cardiovascular Medical Education During the Coronavirus Disease 2019 Pandemic: Challenges, Adaptations, and Considerations for the Future
por: Hilary Shapiro, et al.
Publicado: (2021)

A cross sectional study of atherogenic index of plasma and angiographic profile by Gensini score in patients of Acute Coronary Syndrome
por: Bharavi Chunduri, et al.
Publicado: (2021)

Strategies to Reduce Radiation Exposure in Electrophysiology and Interventional Cardiology
por: Sandeep Shankar, et al.
Publicado: (2020)

Cardiac Transthyretin-derived Amyloidosis: An Emerging Target in Heart Failure with Preserved Ejection Fraction?
por: Sebastiaan HC Klaassen, et al.
Publicado: (2020)

The Dilemma of Peri-Procedural Warfarin Management: A Narrative Review
por: Islam Eljilany MSc, et al.
Publicado: (2021)

Cost-effectiveness of Platelet Function-Guided Strategy with Clopidogrel or Ticagrelor
por: Nikita Lomakin, et al.
Publicado: (2019)

Telemonitoring in Heart Failure Management
por: Ivo Planinc, et al.
Publicado: (2020)

Management of Cardiac Sarcoidosis in 2020
por: Nisha Gilotra, et al.
Publicado: (2020)

Evaluation and Management of Heart Block After Transcatheter Aortic Valve Replacement
por: Anthony J Mazzella, et al.
Publicado: (2021)

Intracoronary fibrinolysis: An effective yet underutilized therapeutic strategy in clinical practice
por: Kenan Yalta, et al.
Publicado: (2021)

Telemonitoring for the Management of Patients with Heart Failure
por: Ferdinando Iellamo, et al.
Publicado: (2020)

Contemporary Management of Secondary Mitral Regurgitation
por: Kashish Goel, et al.
Publicado: (2020)

Cardiac MRI to Manage Atrial Fibrillation
por: Yan Zhao, et al.
Publicado: (2020)

Brugada Syndrome: Progress in Diagnosis and Management
por: Carlo Pappone, et al.
Publicado: (2019)

Comment on ‘Management of Cardiac Sarcoidosis in 2020’
por: Socrates Korovesis, et al.
Publicado: (2021)

Medical Therapy Following Urgent/Emergent Revascularization in Peripheral Artery Disease Patients (Canadian Acute Limb Ischemia Registry [CANALISE I])
por: Eric Kaplovitch, BSc(H), MD, FRCPc, et al.
Publicado: (2021)

The Limitations of Symptom-based Heart Failure Management
por: Lampros Papadimitriou, et al.
Publicado: (2019)

Digital Health: Implications for Heart Failure Management
por: Arvind Singhal, et al.
Publicado: (2021)

The Future of Telemedicine in the Management of Heart Failure Patients
por: José Silva-Cardoso, et al.
Publicado: (2021)

Post-thrombotic Syndrome: Preventative and Risk Reduction Strategies Following Deep Vein Thrombosis
por: Adam M Gwozdz, et al.
Publicado: (2020)

Strategies to Reduce Recurrent Shocks Due to Ventricular Arrhythmias in Patients with an Implanted Cardioverter-Defibrillator
por: Steven H Back, et al.
Publicado: (2019)

Hypertensive Disorders in Pregnancy and the Risk of Cardiovascular Disease: A Need for Postpartum Strategies for the Primary Prevention
por: Ajay K. Gupta
Publicado: (2018)

Coronavirus Disease 2019 Myocarditis: Insights into Pathophysiology and Management
por: Mahmoud Abdelnabi, et al.
Publicado: (2020)

The Role of Wearable Technologies and Telemonitoring in Managing Vascular Disease
por: Calvin Chan, et al.
Publicado: (2020)

Spontaneous Coronary Artery Dissection: Mechanisms, Diagnosis and Management
por: Marcos Garcia-Guimarães, et al.
Publicado: (2020)

Atrial Fibrosis: Translational Considerations for the Management of AF Patients
por: Stylianos Tzeis, et al.
Publicado: (2019)

Remote Management of Heart Failure: An Overview of Telemonitoring Technologies
por: Darshan H Brahmbhatt, et al.
Publicado: (2019)

Brugada Syndrome: Progress in Genetics, Risk Stratification and Management
por: Jorge Romero, et al.
Publicado: (2019)

The 2020 ESC Guidelines on the Diagnosis and Management of Atrial Fibrillation
por: Agnieszka Kotalczyk, et al.
Publicado: (2021)

Progress continues on the management of pulmonary arterial hypertension in pregnancy
por: Hannah Douglas, et al.
Publicado: (2021)

Frequency and Determinants of Spontaneous Conversion to Sinus Rhythm in Patients Presenting to the Emergency Department with Recent-onset Atrial Fibrillation: A Systematic Review
por: Nikki AHA Pluymaekers, et al.
Publicado: (2020)

Acute Heart Failure in Coronavirus Disease 2019 and the Management of Comedications
por: Chia Siang Kow, et al.
Publicado: (2020)